Back to search
FDAFDA · Food and drugs·Recall number D-0439-2024

Isotretinoin Capsules, USP 40mg, 30-count 3x10 blister packs per carton, Rx Only, Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054. Blister Pack NDC 0591-2436-45, Carton NDC 0591-2436-15

Published April 17, 2024 · Recall initiated: March 28, 2024

Summary

FDA records drug Class II recall D-0439-2024, published April 17, 2024 and initiated March 28, 2024. Recalling firm: Teva Pharmaceuticals USA, Inc; Status: Ongoing; Reported quantity: 5,304 3x10-cartons; Lot: Lot #: 100044259, Exp 06/30/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Superpotent Drug: The 3-month stability result for assay was found to be above specification limit

What to do

Voluntary: Firm initiated · Letter

Get an email if ISOTRETINOIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ISOTRETINOIN
Manufacturer
Teva Pharmaceuticals USA, Inc
Distributor
Nationwide in the USA
Lot
Lot #: 100044259, Exp 06/30/2025.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Isotretinoin Capsules, USP 40mg, 30-count 3x10 blister packs per carton, Rx Only, Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054. Blister Pack NDC 0591-2436-45, Carton NDC 0591-2436-15 recalled?

Yes. FDA published recall D-0439-2024 on April 17, 2024. Reported hazard: Superpotent Drug: The 3-month stability result for assay was found to be above specification limit

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ISOTRETINOIN.